supp.fit

Vitamin B12, Vitamin B6 and Vitamin B9: study protocols

12 study groups took Vitamin B12 together with Vitamin B6 and Vitamin B9. These are the doses the studies gave. They are not a recommendation.

Vitamin B12: what the research found →

Dose per serving from research: Vitamin B12

12 study groups in 9 studies say how much Vitamin B12 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mcg to 1 mg, 50% of 12 study groups.

Daily doseStudy groups
10 mcg or less
1
10 mcg to 25 mcg
2
25 mcg to 50 mcg
0
50 mcg to 100 mcg
0
100 mcg to 250 mcg
0
250 mcg to 500 mcg
3
500 mcg to 1 mg
6

Dose per serving from research: Vitamin B6

10 study groups in 8 studies say how much Vitamin B6 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 60% of 10 study groups.

Daily doseStudy groups
1 mg or less
1
1 mg to 2.5 mg
0
2.5 mg to 5 mg
2
5 mg to 10 mg
0
10 mg to 25 mg
0
25 mg to 50 mg
6
50 mg to 100 mg
1

Dose per serving from research: Vitamin B9

11 study groups in 9 studies say how much Vitamin B9 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 45% of 11 study groups.

Daily doseStudy groups
250 mcg or less
1
250 mcg to 500 mcg
1
500 mcg to 1 mg
2
1 mg to 2.5 mg
1
2.5 mg to 5 mg
0
5 mg to 10 mg
1
10 mg to 25 mg
5

Commonly used together

3 of 12 study groups took Vitamin B12, Vitamin B6 and Vitamin B9 with something else, but nothing that 3 or more different studies gave.

12 study groups

Study
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial
2014 · B vitamins only · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke
20 mcg3 mg560 mcg1716 days—
Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study
2022 · Mg-Teadiola · Adults aged 18–65, either sex, otherwise healthy and chronically stressed (DASS-42 stress score ≥14)
1.25 mcg700 mcg100 mcg4 weeks51
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial
2014 · B vitamins plus n-3 fatty acids · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke
20 mcg3 mg560 mcg1716 days—
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folinic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
1 mg50 mg20 mg12 weeks22
Effect of Methylfolate, Pyridoxal-5'-Phosphate, and Methylcobalamin (Soloways(TM)) Supplementation on Homocysteine and Low-Density Lipoprotein Cholesterol Levels in Patients with Methylenetetrahydrofolate Reductase, Methionine Synthase, and Methionine Synthase Reductase Polymorphisms: A Randomized Controlled Trial
2024 · methylfolate, P5P, and methylcobalamin · Adults aged 40–75 with elevated homocysteine, LDL-C of 70–190 mg/dL, and at least one minor allele in a specified MTHFR, MTR, or MTRR polymorphism
1 mg100 mg2 mg180 days27
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg50 mg17 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
1 mg50 mg17 mg12 weeks25
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · L-folinic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg50 mg20 mg12 weeks24
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving MTHF · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
1 mg50 mg17 mg12 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 1 · Chronic haemodialysis patients; age and sex not specified
429 mcg——26 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 2 · Chronic haemodialysis patients; age and sex not specified
429 mcg—7.14 mg26 weeks—
Effect of adding B-vitamins to vitamin D and calcium supplementation on CpG methylation of epigenetic aging markers
2018 · D + Ca + B · Adults, mean age 68.4 years; no specific condition stated
500 mcg50 mg500 mcg1 year32